@conlan_ciara @aoifekirk @AccessToMedsIRL @gaellekrikorian @MSF_access I'm somewhat pessimistic about the prospects of beneluxa https://t.co/kagAYokeiV https://t.co/5yYJ2ub15n
RT @PECjournal: @PaulaLorgelly @ruth_howells @RitaINdeFaria @NICEcomms @jamesfomahony wrote an editorial on prospects for the @BeneluxaCoop…
@PaulaLorgelly @ruth_howells @RitaINdeFaria @NICEcomms @jamesfomahony wrote an editorial on prospects for the @BeneluxaCoop to share work/resources https://t.co/eyTlVBVfiM
Collective bargaining on common prices an unlikely outcome from @BeneluxaCoop. The best one can hope for is partial HTA https://t.co/StZZKYcQt4
RT @jamesfomahony: My editorial in PharmacoEconomics on why I believe the benefits of Beneluxa will be limited. https://t.co/kagAYo2CUl htt…
RT @HealthEconBot: #HealthEconJA Beneluxa: What are the Prospects for Collective Bargaining on Pharmaceutical Prices Given Diverse Health T…
RT @jamesfomahony: My editorial in PharmacoEconomics on why I believe the benefits of Beneluxa will be limited. https://t.co/kagAYo2CUl htt…
RT @jamesfomahony: My editorial in PharmacoEconomics on why I believe the benefits of Beneluxa will be limited. https://t.co/kagAYo2CUl htt…
My editorial in PharmacoEconomics on why I believe the benefits of Beneluxa will be limited. https://t.co/kagAYo2CUl https://t.co/gMhQUDgdrC
#HealthEconJA Beneluxa: What are the Prospects for Collective Bargaining on Pharmaceutical Prices Given Diverse Health Technology Assessment Processes? https://t.co/SpFh2Lvdyh